Cargando…

Tubeimoside I Ameliorates Doxorubicin-Induced Cardiotoxicity by Upregulating SIRT3

Cardiotoxicity linked to doxorubicin (DOX) is primarily caused by inflammation, oxidative stress, and apoptosis. The role of tubeimoside I (TBM) in DOX-induced cardiotoxicity remains ambiguous, despite growing evidence that it could reduce inflammation, oxidative stress, and apoptosis in various dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Wei, Fan, Zhixing, Wang, Fengyuan, Yin, Lin, Wu, Jinchun, Li, Dengke, Song, Siwei, Wang, Xi, Tang, Yanhong, Huang, Congxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867588/ https://www.ncbi.nlm.nih.gov/pubmed/36691640 http://dx.doi.org/10.1155/2023/9966355

Ejemplares similares

Tubeimoside I Ameliorates Myocardial Ischemia-Reperfusion Injury through SIRT3-Dependent Regulation of Oxidative Stress and Apoptosis
por: Lv, Dingyi, et al.
Publicado: (2021)

Cardiac SIRT1 ameliorates doxorubicin-induced cardiotoxicity by targeting sestrin 2
por: Wang(a), Jie, et al.
Publicado: (2022)

Overexpressed SIRT6 ameliorates doxorubicin-induced cardiotoxicity and potentiates the therapeutic efficacy through metabolic remodeling
por: Peng, Kezheng, et al.
Publicado: (2023)

Dimethyl Fumarate Ameliorates Doxorubicin-Induced Cardiotoxicity By Activating the Nrf2 Pathway
por: Hu, Xiaoliang, et al.
Publicado: (2022)

Dipyridamole ameliorates doxorubicin-induced cardiotoxicity
por: Alyasiry, Esraa, et al.
Publicado: (2022)

Berberine Ameliorates Doxorubicin-Induced Cardiotoxicity via a SIRT1/p66Shc-Mediated Pathway
por: Wu, Yan-Zhao, et al.
Publicado: (2019)

Resveratrol and FGF1 Synergistically Ameliorates Doxorubicin-Induced Cardiotoxicity via Activation of SIRT1-NRF2 Pathway
por: Lu, Guangping, et al.
Publicado: (2022)

RNA m(6)A-Regulated circ-ZNF609 Suppression Ameliorates Doxorubicin-Induced Cardiotoxicity by Upregulating FTO
por: Yu, Pujiao, et al.
Publicado: (2023)

Evaluation of Ameliorative Effect of Quercetin and Candesartan in Doxorubicin-Induced Cardiotoxicity
por: Majhi, Sagarika, et al.
Publicado: (2022)

Protection against Doxorubicin-Related Cardiotoxicity by Jaceosidin Involves the Sirt1 Signaling Pathway
por: Liu, Yuzhou, et al.
Publicado: (2021)

Tubeimoside I-induced lung cancer cell death and the underlying crosstalk between lysosomes and mitochondria
por: Wang, Kun, et al.
Publicado: (2020)

Chrysanthemum morifolium Extract Ameliorates Doxorubicin-Induced Cardiotoxicity by Decreasing Apoptosis
por: Ono, Masaya, et al.
Publicado: (2022)

Seaweed Sargassum aquifolium extract ameliorates cardiotoxicity induced by doxorubicin in rats
por: Samir, Rania, et al.
Publicado: (2023)

Anti-microtubule activity of tubeimoside I and its colchicine binding site of tubulin
por: Ma, Rundi, et al.
Publicado: (2007)

Pharmacokinetics and Bioavailability Study of Tubeimoside I in ICR Mice by UPLC-MS/MS
por: Chen, Lianguo, et al.
Publicado: (2018)

Tubeimoside I Antagonizes Yoda1-Evoked Piezo1 Channel Activation
por: Liu, Silin, et al.
Publicado: (2020)

PGC1α activation by pterostilbene ameliorates acute doxorubicin cardiotoxicity by reducing oxidative stress via enhancing AMPK and SIRT1 cascades
por: Liu, Dong, et al.
Publicado: (2019)

Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes
por: Zhao, Liqun, et al.
Publicado: (2017)

Upregulation of Biomarker Limd1 Was Correlated with Immune Infiltration in Doxorubicin-Related Cardiotoxicity
por: Zhang, Rui, et al.
Publicado: (2023)

Tripartite motif 25 ameliorates doxorubicin-induced cardiotoxicity by degrading p85α
por: Shen, Yihui, et al.
Publicado: (2022)

Integrating Metabolomics and Network Pharmacology to Explore the Mechanism of Tongmai Yangxin Pills in Ameliorating Doxorubicin-Induced Cardiotoxicity
por: Shu, Lexin, et al.
Publicado: (2023)

Adjuvant activity of tubeimosides by mediating the local immune microenvironment
por: Han, Ziyi, et al.
Publicado: (2023)

Nicorandil Ameliorates Doxorubicin-Induced Cardiotoxicity in Rats, as Evaluated by 7 T Cardiovascular Magnetic Resonance Imaging
por: Wan, Yixuan, et al.
Publicado: (2021)

Protective Effects of Oroxylin A against Doxorubicin-Induced Cardiotoxicity via the Activation of Sirt1 in Mice
por: Zhang, Wen-Bin, et al.
Publicado: (2021)

Roflumilast Attenuates Doxorubicin-Induced Cardiotoxicity by Targeting Inflammation and Cellular Senescence in Cardiomyocytes Mediated by SIRT1
por: Zhang, Sheng, et al.
Publicado: (2021)

SIRT1 activation and its effect on intercalated disc proteins as a way to reduce doxorubicin cardiotoxicity
por: Podyacheva, Ekaterina, et al.
Publicado: (2022)

Hyperhomocysteinaemia Promotes Doxorubicin-Induced Cardiotoxicity in Mice
por: Fan, Rui, et al.
Publicado: (2023)

INKing the Cardiotoxicity Out of Doxorubicin
por: Guo, Zhen, et al.
Publicado: (2023)

Role of acetylation in doxorubicin-induced cardiotoxicity
por: Li, Daisong, et al.
Publicado: (2021)

Folic acid ameliorates celecoxib cardiotoxicity in a doxorubicin heart failure rat model
por: Ahmad, Shafique, et al.
Publicado: (2017)

miR-200a Attenuated Doxorubicin-Induced Cardiotoxicity through Upregulation of Nrf2 in Mice
por: Hu, Xiaoping, et al.
Publicado: (2019)

Qishen Yiqi Dropping Pills Ameliorates Doxorubicin-Induced Cardiotoxicity in Mice via Enhancement of Cardiac Angiogenesis
por: Wang, Lijiang, et al.
Publicado: (2019)

Erratum: SIRT1 activation and its effect on intercalated disc proteins as a way to reduce doxorubicin cardiotoxicity
por: Frontiers Production Office,
Publicado: (2023)

Epigallocatechin-3-gallate pretreatment alleviates doxorubicin-induced ferroptosis and cardiotoxicity by upregulating AMPKα2 and activating adaptive autophagy
por: He, Huan, et al.
Publicado: (2021)

Water Extract of Capsella bursa-pastoris Mitigates Doxorubicin-Induced Cardiotoxicity by Upregulating Antioxidant Enzymes
por: Jeong, Yuhui, et al.
Publicado: (2023)

Honokiol protects against doxorubicin cardiotoxicity via improving mitochondrial function in mouse hearts
por: Huang, Lizhen, et al.
Publicado: (2017)

GCN2 deficiency ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and myocardial oxidative stress
por: Wang, Yue, et al.
Publicado: (2018)

Combat Doxorubicin Cardiotoxicity With the Power of Mitochondria Transfer
por: Wang, Dennis D., et al.
Publicado: (2021)

Bibliometric and visual analysis of doxorubicin-induced cardiotoxicity
por: Lin, Xiaoxiao, et al.
Publicado: (2023)

Protection against Doxorubicin-Induced Cardiotoxicity by Ergothioneine
por: Cheah, Irwin K., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f6mij8dqjqn4iccsb5k5nfpblo